Risk Disclaimer

The positions in this portfolio are incredibly risky and extremely volatile.


No one at Get Irked is a professional financial adviser (or a doctor), so consult with your own financial adviser to see if any of these positions fit your risk profile (and stomach).


Trades in Play – January 18, 2019


Highlights from the Week


Rite Aid (RAD) returned from the dead with a whopping 18.76% gain for the week. I have an incredibly small position in RAD due to its volatility and speculative nature, but I am now up in the trade.

Tencent Music (TME) popped 11.24% after the U.S.-China Trade announcement came out. TME completely recovered its Year-To-Date losses, closing the week up 8.55% on the year.

General Electric (GE) continues to edge higher, gaining 1.46%. The smart money is taking their gains and getting out. Although GE had dropped to incredibly oversold levels, that was more than 20% lower and the fundamentals for this one haven’t improved.


This Week’s Trades

• I added to Aurora Cannabis (ACB) when news came out that they’re seeking a convertible loan for $250 million. Although this news weighed on the stock, additional funds for investment are what companies in this sector desperately need. My current per-share cost is $5.91. ACB closed the week at $6.42 leaving us up 8.56%.

• After selling a lot of my Canopy Growth (CGC) last week at $40.00, I picked up some more at $37.62 this week before it continued to rocket higher, closing the week at $43.43 and leaving us up 1,192.56% from our now $3.36 per share cost basis (on a much smaller number of shares).

Corbus Pharma (CRBP) pulled back this week, allowing me to pick up more in the mid $7.50s. My current per-share cost is $5.92. CRBP closed the week at $7.62, leaving us up 28.80%.

Cronos (CRON) saw a huge pop along with its cannabis friends. I took some profit at $14.73 lowering my per-share cost to $7.75. CRON closed the week at $14.85, leaving us up 91.61%.

Novamax (NVAX) pulled back this week. I added to my position at $2.13 and $2.07. My current per-share cost is $1.60. NVAX closed the week at $2.08, leaving us up 29.64%.

Rite Aid’s (RAD) pop caught me off-guard, with me protecting capital by selling quite a bit at $0.86 leaving me with a per-share cost at $0.74. RAD closed the week at $0.98, leaving us up 32.43% but feeling bad because we sold too early and should have waited for the run to edge higher.

Square (SQ) jumped over $70.00 per share this week. I sold the remainder of my position at $68.93 and am now looking to re-enter the stock on a pullback. SQ closed the week at $72.24 leaving us with a total trade profit of 10.39% and wanting to re-enter.

Tencent Music (TME) started moving before the U.S.-China news so we lightened up a tiny bit at $13.03, lowering our per-share cost to $12.31. TME closed the week way up at $14.45, leaving us up 17.41%.

Transenterix (TRXC) continues to jump around our cost basis. We bought some last week at $2.68, sold at $2.83 this week, bought some more later this week at $2.66, and sold some more at $2.86 again this week. We ended up lowering our per-share cost to $2.78. TRXC closed the week at $2.84, leaving us up 2.34%.


Speculative Holdings Status

Year-To-Date Performance: +13.26%
Cash: 76.03%
Invested: 23.97%


Don't get mad, Get Irked and learn how to invest for yourself!


Disclaimer: Eric "Irk" Jacobson and all other Get Irked contributors are not investment or financial advisers. All strategies, trading ideas, and other information presented comes from non-professional, amateur investors and traders sharing techniques and ideas for general information purposes.

As always, all individuals should consult their financial advisers to determine if an investing idea is right for them. All investing comes with levels of risk with some ideas and strategies carrying more risk than others.

As an individual investor, you are accountable for assessing all risk to determine if the strategy or idea fits with your investment style. All information on Get Irked is presented for educational and informational purposes only.